Postdoctoral Fellow in Computational Cancer Metabolism
Memorial Sloan Kettering Cancer Center
Location: New York, New York
Academic / Research
Internal Number: 54994
At Memorial Sloan Kettering (MSK), we're not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing forward with innovation and discovery, we're driving excellence and improving outcomes. We're treating cancer, one patient at a time. Join us and make a difference every day.
In compliance with applicable State regulatory authorities, COVID-19 vaccination is mandatory for all MSK staff. Staff are considered fully vaccinated upon completion of a primary vaccination series for COVID-19 (i.e., one dose of a single dose vaccine or a final dose of a multi-dose vaccine series). Exceptions from the COVID-19 vaccine requirement are permitted for those who request and receive an approved medical or fully remote exemption. Requests for medical exemption can take up to two weeks to review. Vaccination or an approved medical exemption is required to start work.
*Staff working at a MSK New Jersey location must be up to date with COVID-19 vaccination, which includes having completed the primary COVID-19 vaccination series and booster once eligible as mandated by New Jersey State. All New Jersey staff not yet eligible for a booster must receive a booster within 3 weeks of becoming eligible as a condition of continued employment at MSK.
Note: Individuals are eligible to receive a COVID-19 booster two months after completion of a primary vaccination series for COVID-19. Because vaccine-induced immunity can wane over time, MSK continues to strongly urge all staff to get a COVID-19 booster as soon as they become eligible to maintain their protective immunity for a longer period.
We are seeking postdoctoral fellows to join the Reznik Laboratory for Computational Cancer Metabolism at Memorial Sloan Kettering Cancer Center in New York. Our research group investigates basic and translational problems at the interface of cancer genomics, tumor metabolism, and mitochondrial genetics using multimodal datasets.
The chosen candidate will lead new and highly collaborative projects applying bulk and single cell sequencing technologies to understand the functional and therapeutic significance of somatic mitochondrial DNA mutations in cancer biology. They will join a diverse group of quantitative geneticists, genomicists, and machine learners embedded in the Computational Oncology Service, a new initiative dedicated to translational, data-driven cancer science and tightly integrated with the work of MSK's clinicians.
Competitive candidates should must have
PhD in a computational or quantitative discipline including but not limited to computational biology, bioengineer, computer science, physics, or bioinformatics.
A research background in cancer genomics is preferred but not necessary.
Learn more about the Computational Oncology service at: http://www.CompOncMSK.org
At Memorial Sloan Kettering (MSK), we’re not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing forward with innovation and discovery, we’re driving excellence and improving outcomes. For the 28th year, MSK has been named a top hospital for cancer by U.S. News & World Report. We are proud to be on Becker’s Healthcare list as one of the 150 Great Places to Work in Healthcare in 2018, as well as one of Glassdoor’s Employees’ Choice Best Place to Work for 2018. We’re treating cancer, one patient at a time. Join us and make a difference every day.